Daily Digest 2026-03-08

Top 50 item(s) from the CED news pipeline as of March 08, 2026.

1. 97 Landmark Clinical FindingAlabama Medical Cannabis Sales Gear for Spring 2026 Launch
2. 97 Landmark Clinical FindingCannabis compounds CBD and CBG may help reverse fatty liver disease, study finds
3. 97 Landmark Clinical FindingFrom Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …
4. 97 Landmark Clinical FindingCannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving …
5. 96 Landmark Clinical FindingNew Cannabis Group Will Help Ground Policy In Science And Patient Experience As …
6. 96 Landmark Clinical FindingNew Top Cannabis Regulator Sets Priorities In First Board Meeting
7. 95 Landmark Clinical FindingBrazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead
8. 95 Landmark Clinical Finding2 Greater Cincinnati breweries file lawsuit over Ohio ban on THC beverages – WLWT
9. 95 Landmark Clinical FindingNew Ohio law means THC-infused drinks won’t be available on many store shelves – WTVG
10. 95 Landmark Clinical FindingLawmakers strike down bill capping THC levels in Oregon’s cannabis edibles – Yahoo
11. 95 Landmark Clinical FindingAttempt to limit potency of THC in marijuana edibles fails at Oregon Legislature
12. 95 Landmark Clinical FindingCannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health
13. 95 Landmark Clinical FindingCannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed
14. 95 Landmark Clinical FindingStudy: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML
15. 95 Landmark Clinical FindingClinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML
16. 95 Landmark Clinical FindingAs a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely
17. 95 Landmark Clinical FindingThe Week in Weed: March 2026 | Seyfarth Shaw LLP – JDSupra
18. 95 Landmark Clinical FindingMarijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch
19. 95 Landmark Clinical FindingNew Group Launches Ahead of Medicare CBD Pilots – Cannabis Wire
20. 95 Landmark Clinical FindingMarijuana Status Based Prohibition Tag Archives – Powers Law Firm PA
21. 95 Landmark Clinical FindingLouisiana lawmaker files bill to legalize recreational marijuana through licensed dispensaries
22. 92 Landmark Clinical FindingMom’s homemade medical cannabis recipe now being sold at Georgia dispensaries
23. 92 Landmark Clinical FindingOhio THC drink ban draws lawsuit from Cincinnati breweries
24. 92 Landmark Clinical FindingIsraeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease
25. 92 Landmark Clinical FindingVirginia adult-use sales bills pass both chambers, head to conference committee! – Blog
26. 92 Landmark Clinical FindingStudy highlights pros, cons of medical marijuana as its future in Tennessee remains unknown
27. 90 Landmark Clinical Finding2026 Utah legislature on cannabis, psychedelics and kratom – Fox 13
28. 90 Landmark Clinical FindingOregon Bill To Ban Marijuana Edibles With More Than 10 Milligrams Of THC Fails
29. 88 High Clinical InterestGeorgia bill could limit probable cause for smell of marijuana, cannabis, or hemp – YouTube
30. 85 High Clinical InterestStudy reveals cannabis compounds reduce threat of fatty liver disease | Health
31. 85 High Clinical InterestPrescription Cannabidiol CBD Oil Market to Hit US$ 190.9 Billion by 2032 at 23.48% CAGR
32. 85 High Clinical InterestTPS Cannabis News – StratCann
33. 85 High Clinical InterestInMed Pharmaceuticals Shifts Focus to Therapeutic Programs, Ends BayMedica’s Non …
34. 85 High Clinical InterestCannabis Extracts Significantly Reduce Myofascial Pain | Trending – Labroots
35. 85 High Clinical InterestPediatricians warn about cannabis use disorder, kids’ easy access to the drug – YouTube
36. 85 High Clinical InterestWest Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some …
37. 85 High Clinical InterestStudy highlights positive, negatives of medical marijuana – WKRN News 2
38. 85 High Clinical InterestThe science behind roadside THC testing and diving into SGI’s zero-tolerance policy – Global News
39. 85 High Clinical InterestMom’s homemade medical cannabis recipe now being sold at Georgia dispensaries
40. 85 High Clinical Interest‘Pot for Potholes Act’ aims to legalize marijuana in Tennessee and distribute taxes to repair …
41. 85 High Clinical InterestOne of Colorado’s Largest Dispensary Chains Agrees to Buyout – Denver Westword
42. 85 High Clinical InterestCannabis legalization driving increases in marijuana use among US adults with historically … – MSN
43. 85 High Clinical InterestOhio Department of Commerce recalls certain marijuana gummies lacking THC symbol … – Facebook
44. 85 High Clinical InterestPerceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon.
45. 84 High Clinical InterestWhat’s Really Happening With Cannabis ETF MSOS? – The Dales Report
46. 82 High Clinical InterestStudy reveals cannabis compounds reduce threat of fatty liver disease – Daily Journal
47. 82 High Clinical InterestScientists are raising new concerns about marijuana use in teens – KPBS
    Research continues to build a concerning picture around adolescent cannabis use and its association with elevated risk for psychiatric conditions, including psychosis, depression, and anxiety disorders. The developing brain, particularly during the teenage years, appears to be especially vulnerable to the neurochemical disruptions that cannabinoids can produce, with THC’s interaction with the endocannabinoid system potentially altering normal neurodevelopmental trajectories. Clinicians and public health researchers are increasingly calling for clearer communication about these risks, particularly as cannabis potency has risen substantially and cultural perception of harm has declined among younger populations.
48. 82 High Clinical InterestClinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML
    Sublingual cannabis extract administration has demonstrated meaningful reductions in myofascial pain among patients with temporomandibular disorders, a condition historically resistant to conventional pharmacological approaches. The findings add to a growing body of evidence supporting cannabinoid-based interventions for chronic orofacial pain, where inflammation and central sensitization play significant roles. Sublingual delivery offers practical advantages in this population, including rapid mucosal absorption and the ability to titrate dosing with reasonable precision.
    📋 Why it matters: Patients with chronic jaw and facial pain who have not found relief through standard treatments now have emerging clinical trial evidence supporting sublingual cannabis extracts as a potential therapeutic option worth discussing with their provider.
49. 81 High Clinical InterestCan the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure
    Emerging research is exploring whether placental biomarkers can serve as early indicators of schizophrenia risk, particularly in the context of prenatal cannabis exposure. THC crosses the placenta and can disrupt fetal neurodevelopment by interacting with the endocannabinoid system during critical windows of brain formation. This line of inquiry raises important questions about how prenatal THC exposure may prime neurobiological pathways associated with psychosis susceptibility later in life.
50. 81 High Clinical InterestScientists are raising new concerns about marijuana use in teens – YouTube
    Adolescent cannabis use remains one of the most clinically significant concerns in cannabis medicine, as the developing brain is uniquely vulnerable to the effects of THC through at least the mid-twenties. Research consistently points to associations between early, frequent cannabis use and disruptions in neurodevelopmental trajectories, including effects on memory, attention, and emotional regulation. The concentration of THC in today’s products is substantially higher than in previous decades, which raises the stakes for any conversation about youth exposure and risk.